Product Description: MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.
Applications: Cancer-programmed cell death
Formula: C28H27F3N8S
References: [1]Borkin D, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13;27(4):589-602.